Nicola Dagg

Nicola Dagg is a partner in the Intellectual Property Team in the London office of Kirkland & Ellis International LLP. Nicola’s practice spans four areas: (1) strategic patent and product lifecycle advice; (2) patent litigation; (3) coordinating global IP enforcement/defence cases; and (4) standard essential patent (SEP) and FRAND disputes.

Nicola has extensive experience on all aspects of intellectual property advisory and litigation work, including blockbuster small molecule litigation against generic companies, biologics and biosimilar litigation, antibodies, immunotherapies, genetics, vaccines, diagnostics and gene therapies. Nicola also acts in market leading SEP essentiality, validity and global FRAND adjudication litigation in the tech sector. Having served as UK and European/global co-ordinating counsel for numerous strategic IP projects litigation cases and drawing on almost 30 years of legal, IP, life sciences and tech experience she helps clients solve their most pressing global IP challenges.